Diagnosis and treatment of myocardial failure
US7482331B1 · kind B1 · utility
1Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2000 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | May 4, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides a method of treating myocardial failure in a human. The method comprises administering an effective amount of transgene encoding α-MHC that directly causes an increase in the quantity of α-MHC in the myocardial tissue of the heart.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.